Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

Helen Young, R. Baum, U. Cremerius et al. · European Journal of Cancer · 1999 · 1.7K citations · Full text

Medicine, Oncology, Radiology +16

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma

Martin Hutchings, Annika Loft, Mads Hansen et al. · Blood · 2005 · 720 citations · Full text

Medicine, Oncology, Chemotherapy +14

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

Corinne Haïoun, Emmanuel Itti, Alain Rahmouni et al. · Blood · 2005 · 497 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding

Yusuf E. Erdi, Osama Mawlawi, Steven M. Larson et al. · Cancer · 1997 · 465 citations

Medicine, Biomedical Engineering, Radiology +14

PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients

Corinna Bürger, Gerhard W. Goerres, S. Schoenes et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 425 citations

Medicine, Nuclear Medicine, Radiology +17